Couverture de Taking Cancer On

Taking Cancer On

Taking Cancer On

De : Boehringer Ingelheim
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

 In an effort to simplify the science behind our ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings. Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval. Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Keith’s Journey With Lung Cancer

      Keith’s Journey With Lung Cancer
      May 25 2022
      Expert Guests: Keith Perry, lung cancer survivor In episode 5, we turn our attention to living with lung cancer. Sebastian speaks to Keith Perry, a lung cancer survivor who took a truly awe-inspiring approach to his recovery journey after losing his left lung to cancer. Disclaimer: This episode reflects the unique experiences of an individual living with lung cancer. The experiences of other people living with lung cancer will vary. You can subscribe to the series on Apple Podcast, Spotify or Deezer to stay up to date on Taking Cancer On.
      Afficher plus Afficher moins
      36 min
    • Helping the Immune System to Take Cancer On

      Helping the Immune System to Take Cancer On
      Nov 24 2021
      Expert Guests: Jose Barrueco, M.D. Ph.D. and Petra Blum, M.D. Ph.D., both leading Global Clinical Development teams in Oncology at Boehringer Ingelheim. In this episode, Jose and Petra discuss cancer immunology and explain what it takes to develop cancer immunotherapies. How can the immune system be used to treat cancer? What is Boehringer Ingelheim contributing to this field? What is the future of cancer immunotherapy? Listen to this episode to find out more!
      Afficher plus Afficher moins
      26 min
    • Collaborating Against Cancer

      Collaborating Against Cancer
      Jun 4 2021
      In this episode, we hear from Dr Scott DeWire, Head of US Business Development at Boehringer Ingelheim (BI) and Dr Andrew Fadden, Head of Corporate Development at Enara Bio about the power of research partnerships in progressing cancer innovation and drug development. Their discussion proves that embracing collaboration is essential in delivering ground-breaking treatments to patients, faster. What do pharmaceutical partnerships entail? What can we gain from collaborating with partners? Do we share the same goals? Listen to this episode to find out more!
      Afficher plus Afficher moins
      29 min
    Aucun commentaire pour le moment